Literature DB >> 206529

Two kinds of mutants defective in multiple carbohydrate utilization isolated from in vitro fosfomycin-resistant strains of Escherichia coli K--12.

T Tsuruoka, A Miyata, Y Yamada.   

Abstract

Two types of in vitro fosfomycin-resistant mutants defective in multiple carbohydrate utilization were selected from Escherichia coli strain K--12. One mutant, FR182, was defective in phosphoenolpyruvate: sugar phosphotransferase system and the ability to form adenosine 3',5'-cyclic monophosphate (cAMP) was lowered. Another mutant, FR190, was defective in cAMP formation. Restoration by cAMP of fosfomycin (FOM) sensitivity coupled with recovery of utilization of many carbohydrates including sn-glycerol-3-phosphate (G-3-P) was observed in both of the resistant mutants. FOM was not taken up by these resistant strains but, in the cells cultured in the presence of cAMP, accumulation of FOM was equivalent to that of the sensitive parent strain. Decreased uptake of G-3-P was also restored in both of the resistant strains cultured in the presence of cAMP. These results indicate that the resistance to FOM in these mutants is due to impairment of G-3-P transport system, one of the pathways for uptake of FOM. They were sensitized to FOM by D-glucose-6-phosphate because of the induction of hexose phosphate transport system, another uptake pathway.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 206529     DOI: 10.7164/antibiotics.31.192

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  14 in total

1.  Mutant isolation and molecular cloning of mre genes, which determine cell shape, sensitivity to mecillinam, and amount of penicillin-binding proteins in Escherichia coli.

Authors:  M Wachi; M Doi; S Tamaki; W Park; S Nakajima-Iijima; M Matsuhashi
Journal:  J Bacteriol       Date:  1987-11       Impact factor: 3.490

Review 2.  Fosfomycin: an old, new friend?

Authors:  M Popovic; D Steinort; S Pillai; C Joukhadar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-14       Impact factor: 3.267

3.  Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate.

Authors:  Miranda E Pitt; Minh Duc Cao; Mark S Butler; Soumya Ramu; Devika Ganesamoorthy; Mark A T Blaskovich; Lachlan J M Coin; Matthew A Cooper
Journal:  J Antimicrob Chemother       Date:  2019-03-01       Impact factor: 5.790

4.  Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake.

Authors:  G Martín-Gutiérrez; F Docobo-Pérez; J Rodriguez-Beltrán; J M Rodríguez-Martínez; J Aznar; A Pascual; J Blázquez
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 5.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

6.  Fosfomycin enhances the active transport of tobramycin in Pseudomonas aeruginosa.

Authors:  David L MacLeod; Jyoti Velayudhan; Thomas F Kenney; Joseph H Therrien; Jennifer L Sutherland; Lynn M Barker; William R Baker
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

7.  Biological costs and mechanisms of fosfomycin resistance in Escherichia coli.

Authors:  Annika I Nilsson; Otto G Berg; Olle Aspevall; Gunnar Kahlmeter; Dan I Andersson
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

8.  Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections.

Authors:  Alexandro Rodríguez-Rojas; María D Maciá; Alejandro Couce; Cristina Gómez; Alfredo Castañeda-García; Antonio Oliver; Jesús Blázquez
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

9.  The glycerol-3-phosphate permease GlpT is the only fosfomycin transporter in Pseudomonas aeruginosa.

Authors:  Alfredo Castañeda-García; Alexandro Rodríguez-Rojas; Javier R Guelfo; Jesús Blázquez
Journal:  J Bacteriol       Date:  2009-09-04       Impact factor: 3.490

10.  fosI Is a New Integron-Associated Gene Cassette Encoding Reduced Susceptibility to Fosfomycin.

Authors:  Karla de Oliveira Pelegrino; Juliana Coutinho Campos; Suely Carlos Ferreira Sampaio; Karina Lezirovitz; Bruna Mara Seco; Mayne de Oliveira Pereira; Darlan Augusto da Costa Rocha; Thomas Jové; Antonio Carlos Nicodemo; Jorge Luiz Mello Sampaio
Journal:  Antimicrob Agents Chemother       Date:  2015-11-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.